Vanda Pharmaceuticals Inc (VNDA) — Cash Flow Reinvestment Rate
Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow Reinvestment Rate of 2.41x as of March 2024, reinvesting $18.23 Million (capex $7.00K plus investments $-18.22 Million) from operating cash flow of $7.57 Million. See Vanda Pharmaceuticals Inc (VNDA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Vanda Pharmaceuticals Inc Cash Flow Reinvestment Rate (2009–2023)
Historical reinvestment intensity for Vanda Pharmaceuticals Inc across 8 annual periods. For the full cash flow conversion analysis, see Vanda Pharmaceuticals Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Vanda Pharmaceuticals Inc (2009–2023)
Year-by-year capital reinvestment analysis for Vanda Pharmaceuticals Inc. See Vanda Pharmaceuticals Inc (VNDA) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 8.40x | $107.54 Million | $12.80 Million | $383.00K | ▲ +423.9% |
| 2022 | 1.60x | $51.28 Million | $31.98 Million | $679.00K | ▲ +34.2% |
| 2021 | 1.19x | $76.70 Million | $64.21 Million | $552.00K | ▲ +49.0% |
| 2020 | 0.80x | $41.50 Million | $51.77 Million | $1.79 Million | ▼ -46.1% |
| 2019 | 1.49x | $68.31 Million | $45.95 Million | $1.02 Million | ▼ -59.3% |
| 2018 | 3.66x | $109.66 Million | $29.99 Million | $25.37 Million | ▲ +71.2% |
| 2015 | 2.14x | $26.60 Million | $12.45 Million | $2.53 Million | ▲ +2915.0% |
| 2009 | 0.07x | $12.00 Million | $169.34 Million | $12.00 Million | — |